Edesa Biotech, Inc. Common Shares (EDSA)

Price$5.46

Value ScoreD

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)204.07%

Price vs S&P 500 (4W)-66.49%

VGM Score52.92

Market Capitalization$48.55M

All Metrics

Book Value / Share (Quarterly)$1.15

P/TBV (Annual)1.66x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.85

Price vs S&P 500 (YTD)276.35%

Gross Margin (TTM)94.65%

Net Profit Margin (TTM)-1935.58%

EPS (TTM)$-1.34

10-Day Avg Trading Volume0.31M

EPS Excl Extra (TTM)$-1.34

EPS (Annual)$-1.93

ROI (Annual)-311.46%

Gross Margin (Annual)94.65%

Net Profit Margin (5Y Avg)-1517.63%

Cash / Share (Quarterly)$1.13

ROA (Last FY)-161.78%

EBITD / Share (TTM)$-1.43

ROE (5Y Avg)-157.84%

Operating Margin (TTM)-1946.75%

Cash Flow / Share (Annual)$-1.03

P/B Ratio4.76x

P/B Ratio (Quarterly)4.56x

Net Income / Employee (Annual)$-362,900

EV / Revenue (TTM)117.23x

Net Interest Coverage (TTM)-7021.32x

ROA (TTM)-75.37%

EV / EBITDA (TTM)15.16x

EPS Incl Extra (Annual)$-1.93

Current Ratio (Annual)10.67x

Quick Ratio (Quarterly)4.67x

3-Month Avg Trading Volume3.28M

52-Week Price Return178.57%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.93

P/S Ratio (Annual)147.66x

Asset Turnover (Annual)0.03x

52-Week High$20.32

Operating Margin (5Y Avg)-1541.38%

EPS Excl Extra (Annual)$-1.93

Tangible BV CAGR (5Y)6.34%

26-Week Price Return212.00%

Quick Ratio (Annual)10.60x

13-Week Price Return51.25%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.76x

Enterprise Value$38.55M

Asset Turnover (TTM)0.04x

Book Value / Share Growth (5Y)-23.44%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)3.05x

Pretax Margin (Annual)-1935.34%

Cash / Share (Annual)$1.51

3-Month Return Std Dev267.29%

Gross Margin (5Y Avg)-12.60%

Net Income / Employee (TTM)$-614,300

ROE (Last FY)-311.46%

Net Interest Coverage (Annual)-168.89x

EPS Basic Excl Extra (Annual)$-1.93

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.34

Receivables Turnover (Annual)0.00x

ROI (TTM)-82.34%

P/S Ratio (TTM)147.66x

Pretax Margin (5Y Avg)-1517.32%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.47

Price vs S&P 500 (52W)154.21%

Year-to-Date Return284.51%

5-Day Price Return-18.39%

EPS Normalized (Annual)$-1.93

ROA (5Y Avg)-111.64%

Net Profit Margin (Annual)-1935.58%

Month-to-Date Return-24.38%

Cash Flow / Share (TTM)$-3.45

EBITD / Share (Annual)$-2.14

Operating Margin (Annual)-1946.72%

ROI (5Y Avg)-157.84%

EPS Basic Excl Extra (TTM)$-1.34

P/TBV (Quarterly)5.62x

P/B Ratio (Annual)1.40x

Inventory Turnover (TTM)1.83x

Pretax Margin (TTM)-1935.34%

Book Value / Share (Annual)$1.74

Price vs S&P 500 (13W)42.99%

Beta1.13x

Revenue / Share (TTM)$0.00

ROE (TTM)-82.34%

52-Week Low$0.72

vGradeD

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q2 26-0.49est. -0.27

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
EDSAEdesa Biotech, Inc. Common Shares	D	—	B	$5.46
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Edesa Biotech is a biotechnology company developing therapies for inflammatory and immune-related diseases. Its lead candidate, EB06, is a monoclonal antibody targeting CXCL10 being developed for vitiligo as a potential steroid-sparing treatment option. The company's pipeline includes additional candidates in various stages of development.